NOTCH1 and cancer: Most patients have additional mutations in other cancer-related genes such as activating mutations in the NOTCH1 and ERBB3 receptors and regulators of signal transduction and cell cycle (Ho et al., 2013; Stephens et al., 2013; Ross et al., 2014; Mitani et al., 2016).